Prenatal Cannabis Exposure and Neurodevelopmental Outcomes at Age 5
Abstract
Children with prenatal cannabis exposure showed significantly higher rates of attention problems, anxiety, and social difficulties at age 5 compared to unexposed controls, after adjusting for confounders including tobacco and alcohol exposure.
Study Summary
This population-based cohort study used linked administrative health data from Ontario, Canada, following 503,065 singleton births from 2007–2012 to age 5. Prenatal cannabis exposure was identified via maternal self-report and ICD codes. Neurodevelopmental outcomes at age 5 were assessed using the Early Development Instrument (EDI), a validated population-level tool measuring physical health, social competence, emotional maturity, language/cognitive development, and communication skills. Children with prenatal cannabis exposure had significantly higher rates of vulnerability in emotional maturity (OR 1.48), social competence (OR 1.37), and language/cognitive development (OR 1.29) after adjusting for tobacco, alcohol, socioeconomic status, and maternal mental health. Effects were dose-dependent — first-trimester-only exposure showed smaller effects than continued use. The study is notable for its large sample size and use of population-level data, though self-reported exposure is a limitation.
Key Findings
- 1Prenatal cannabis exposure associated with OR 1.48 for emotional maturity vulnerability at age 5
- 2Social competence (OR 1.37) and language/cognitive development (OR 1.29) also significantly impaired
- 3Dose-dependent effects — continued use throughout pregnancy worse than first-trimester-only
- 4Effects persisted after adjusting for tobacco, alcohol, SES, and maternal mental health
- 5Large population-based sample (n=503,065) provides high statistical power
Clinical Implications
- Cannabis use during pregnancy should be strongly discouraged at any trimester
- Clinicians should screen pregnant patients for cannabis use and provide evidence-based counseling
- The "cannabis is natural/safe" misconception must be addressed in prenatal care
- Children with prenatal exposure should be monitored for developmental delays
Study Limitations
- Self-reported cannabis exposure subject to underreporting due to stigma
- EDI is a population-level screening tool, not a clinical diagnostic instrument
- Residual confounding from unmeasured variables (stress, nutrition, other substances) possible
- Cannabis potency has increased since the study period — current effects may be larger